Clinical trial
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or…
NCT00423878 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00423878 |
|---|---|
| Title | Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder |
| Official title | Clinical Management of Metabolic Problems in Patients With Schizophrenia |
| Acronym | CAMP |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | Risperidone, Olanzapine, Quetiapine, Aripiprazole |
| Enrollment | 215 |
| Start date | Jan 1, 2007 |
| Primary completion | Oct 1, 2009 |
| Completion | Mar 1, 2010 |
| First posted | Jan 18, 2007 |
| Last update posted | Nov 2, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: